Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 3;109(5):1287-90.
doi: 10.1038/bjc.2013.381. Epub 2013 Jul 16.

Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based study

Affiliations

Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based study

S Beiggi et al. Br J Cancer. .

Abstract

Background: Chronic lymphocytic leukaemia (CLL) patients have an increased risk of other malignancies. This may be due to surveillance bias, treatment or immunosuppression.

Methods: Cohort study of 612 consecutively diagnosed CLL patients in a Canadian province, with comparisons to follicular lymphoma (FL) patients.

Results: Treated CLL patients had a 1.7-fold increased risk of second cancers compared with untreated CLL patients. As compared with untreated FL patients, untreated CLL patients had a two-fold increased incidence of second malignancies.

Conclusion: Chronic lymphocytic leukaemia patients have an inherent predisposition to second cancers and the incidence is further increased by treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Site-specific incidence rates of second malignancies in CLL patients as compared with FL patients and the general population of Manitoba, by gender. Unadjusted incidence rates are calculated from 1998 to 2009 and are expressed per 100 000 persons. CLL=chronic lymphocytic leukaemia; F=female; FL=follicular lymphoma; GP=general population; M=male.

References

    1. Chen AC, Halliday GM, Damian DL. Non-melanoma skin cancer: carcinogenesis and chemoprevention. Pathology. 2013;45 (3:331–341. - PubMed
    1. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990–4997. - PubMed
    1. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509.
    1. García JB, Suárez-Varela MM, Vilata JJ, Marquina A, Pallardó L, Crespo J. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region. Acta Derm Venereol. 2013;93:422–427. - PubMed
    1. Greene MH, Hoover RN, Fraumeni JF., Jr Subsequent cancer in patients with chronic lymphocytic leukemia—a possible immunologic mechanism. J Natl Cancer Inst. 1978;61:337–340. - PubMed

Publication types